Analysts think INSM stock price could increase by 15%
Jul 07, 2025, 11:26 AM
4.86%
What does INSM do
Insmed is a biopharmaceutical company based in Bridgewater, New Jersey, focusing on therapies for rare diseases, employing 912 staff. Its key products include ARIKAYCE, brensocatib, and TPIP for various lung diseases.
20 analysts think INSM stock price will increase by 14.72%. The current median analyst target is $112.20 compared to a current stock price of $97.80. The lowest analysts target is $93.03 and the highest analyst target is $131.25.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
